When people think of aging, the focus is usually on the face and body, specifically the breasts, legs, or abdominal area. The hands, one of the most routinely visible parts of the body and one of the first to show signs of aging, are often overlooked.
Hand aging is characterized by a loss of tissue volume and elasticity of the skin, making the back of the hands appear dull and shriveled. This loss of volume likewise increases the visibility of veins on the back of the hands, further affecting their appearance.
Men and women nationwide are turning to hand rejuvenation. Hand rejuvenation commonly refers to numerous treatments, either done separately or in conjunction, that rejuvenate the hands, providing a full and youthful look. Two ideal procedures to rejuvenate the hands are Radiesse and sclerotherapy. Although either one is effective on its own, the combination often leads to superior results.
Depending on the specific characteristics of a patient’s hand, the soft tissue filler Radiesse may often be recommended as a first course of treatment. Radiesse treatments are quick and safe, with little to no recovery period required. Results typically last 1 year, if not longer.
During the procedure, Radiesse is injected into target areas of the hands, which plumps the skin and soft tissue overlying veins, ligaments, and bones made overtly visible from aging, thereby masking their appearance.
Sclerotherapy is a simple procedure where veins are injected with a liquid sclerosing solution, causing them to decrease in size and thereby fade from view. The treatment only eliminates abnormal veins that are no longer used, so there are typically no negative effects on blood circulation of the hand.
Treatments are nearly painless and have very little downtime. Sclerotherapy treatments have a high approval rating from patients as it provides significant long-lasting results.
About The Author
Daniel P. Friedmann, M.D. is a fellowship-trained, board-certified dermatologist and phlebologist at Westlake Dermatology and Clinical Research Director of the Westlake Clinical Research Center.